NCT05872763Completed
A Study of Participants in China With Non-Small-Cell Lung Cancer That is Unable to be Treated With Surgery
An Observational Cohort Study of Patients With Newly Diagnosed Unresectable Stage IIIB, IIIC, or IV Non-Small-Cell Lung Cancer (NSCLC) in China
Source: ClinicalTrials.gov · Last updated 13 Aug 2026
Brief summary (registry, in English)
This is a multicenter, observational cohort study in China with both primary prospective data collection and retrospective collection of prior treatment information from medical records, which enrolls and follows patients who are newly diagnosed with unresectable stage IIIB/IIIC/IV Non-Small-Cell Lung Cancer (NSCLC) in the selected sites. This study aims to describe the clinical practice and long-term survival benefits of patients newly diagnosed with unresectable stage IIIB/IIIC/IV NSCLC. The study also seeks to explore the condition of biomarker tests utilization, and to assess potential economic impact on patients in the real world. The safety related events will also be summarized in this study.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 901 (actual)
- First submitted
- 16 May 2023
- Start date
- 11 Aug 2023
- Primary completion date
- 18 Mar 2026
- Lead sponsor
- Hoffmann-La Roche
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT05872763
What you commit to
- Study type: Observational
- Participants enrolled: 901
- From 11 Aug 2023 to the primary completion date, 18 Mar 2026
- 12 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Participants who have received prior systematic treatment for unresectable Stage IIIB/IIIC/IV NSCLC
Other illness
- Participants who have participated in any anti-cancer, regimen-specified clinical study of first-line treatment for unresectable Stage IIIB/IIIC/IV NSCLC
Who the study is looking for
- Cohort 1:
- Participants who have diagnosed with unresectable stage IIIB/IIIC/IV NSCLC
- Participants who have been diagnosed six months before the start of the study were required to have two complete tumor assessments within at least 6 months intervals after the diagnosis
- Participants who were newly diagnosed within six months before the start of the study were required to have complete baseline information (see section 6.4.1)
- Participants who have received standard first-line treatment defined by guideline CSCO (https://www.csco.org.cn/cn/index.aspx) and NCCN (https://www.nccn.org/)
- Cohort 2:
- Participants who are newly diagnosed with unresectable Stage IIIB/IIIC/IV NSCLC after the start of the study
- Participants who are able to be followed up by the participating site
- Participants planned to receive first line anti-cancer treatment targeting unresectable stage IIIB/IIIC/IV NSCLC in the study site after study initiation
Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Chest Hospital Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Cancer Hospital, Chinese Academy of Medical Sciences Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Sichuan Provincial Cancer Hospital Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
| Harbin Medical University Cancer Hospital Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
| Shandong Cancer Hospital Coordinator of this site? Confirm its status | Jinan | China | Unknown status |
| Jiangsu Province Hospital (the First Affiliated Hospital With Nanjing Medical University) Coordinator of this site? Confirm its status | Nanjing | China | Unknown status |
| Guangxi Cancer Hospital of Guangxi Medical University Coordinator of this site? Confirm its status | Nanning | China | Unknown status |
| The Fourth Hospital of Hebei Medical University Coordinator of this site? Confirm its status | Shijiazhuang | China | Unknown status |
| Shanxi Province Cancer Hospital Coordinator of this site? Confirm its status | Taiyuan | China | Unknown status |
| Hubei Cancer Hospital Coordinator of this site? Confirm its status | Wuhan | China | Unknown status |
| First Affiliated Hospital of Medical College of Xi'an Jiaotong University Coordinator of this site? Confirm its status | Xi'an | China | Unknown status |
| The First Affiliated Hospital of Zhengzhou University Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.